SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

UroGen Reports Data From Pivotal OLYMPUS Trial Evaluating Jelmyto In Patients With Low-Grade Upper Tract Urothelial Cancer

Benzinga · 05/15/2020 13:04